98%
921
2 minutes
20
ObjectiveRhinoplasty maneuvers at the time of cleft lip (CL) repair remain controversial. Particularly, the impact of primary rhinoplasty (PR) on patient-reported outcomes (PROs) and quality of life (QoL) is largely unknown. This study aims to compare PROs and QoL in patients with CL who did or did not undergo PR.DesignRetrospective study.SettingAcademic tertiary care center.Patients, ParticipantsPatients with CL who completed the CLEFT-Q from 2021 to 2024 and had undergone definitive CL repair at our institution.InterventionsPR or no primary rhinoplasty (NPR) at the time of CL repair.Main Outcome Measure(s)The primary outcome was CLEFT-Q scores across facial appearance, health-related QoL, and facial function domains.ResultsA total of 109 patients with 110 CLEFT-Q responses were included. 22% (n = 24) underwent NPR and 78% (n = 85) PR at time of CL repair. Median age at lip repair was 4.6 [1.6] months, and at CLEFT-Q survey was 10.2 [1.6] years. Among those with intermediate rhinoplasty, nose scores were significantly higher in PR compared to NPR on overall (75 vs. 57, P = .026) and unilateral CL analysis (75 vs. 57, = .018). NPR patients were significantly more likely to undergo intermediate rhinoplasty than PR patients (71%, n = 17 vs 33%, n = 28, < .001).ConclusionsPR is associated with improved self-perception of nasal appearance in school-aged children with CL compared to those who did not undergo PR.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/10556656251355040 | DOI Listing |
AJP Rep
July 2025
Allo Hope Foundation, Tuscaloosa, Alabama.
Objective: The purpose of this study was to investigate mental health and impacts upon daily life in patients with a history of pregnancy alloimmunization, and secondarily to examine the relationship between disease severity and quality of care on these outcomes.
Study Design: This was a survey administered between November 2022 and February 2023 to U.S.
Diabetes Metab Syndr Obes
September 2025
Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia.
Insulin therapy remains a cornerstone in the management of type 2 diabetes mellitus (T2DM), especially in patients experiencing progressive loss of pancreatic beta-cell function or those with inadequate glycemic control despite oral antidiabetic therapy. This review synthesized clinical outcomes from 44 peer-reviewed case reports published between 2019 and 2024, identified through systematic searches in PubMed and Scopus. The included cases involved 15 males and 29 females, with patient ages ranging from 11 to 91 years (mean 53 ± 20.
View Article and Find Full Text PDFJB JS Open Access
September 2025
University of Glasgow, Glasgow, United Kingdom.
Background: Open fractures are common and severe injuries that are associated with poor functional outcomes and quality of life, and high societal costs. Several classifications systems have been developed to characterize these injuries, predict prognosis and plan treatment. We aimed to assess the agreement between open fracture classification and patient-reported function, fracture-related infection, and amputation.
View Article and Find Full Text PDFJ Multidiscip Healthc
September 2025
School Public Health and Social Work, Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia.
Background: Diabetes mellitus is a major health challenge among older adults in Asia. Challenges include limited healthcare access and poor self-care adherence. Continuity of care has emerged as a key strategy to enhance diabetes self-management in this population.
View Article and Find Full Text PDFFront Allergy
August 2025
Department of Surgery, University of Auckland, Auckland, New Zealand.
Allergic rhinitis (AR) and chronic rhinosinusitis (CRS) are common respiratory conditions that significantly impact patient health and contribute to substantial healthcare burdens. While conventional treatments offer symptom relief, many patients continue to experience persistent symptoms, side effects, or resistance to standard therapies. This highlights the growing need for novel, non-invasive, and sustainable therapeutic strategies to manage chronic airway inflammation.
View Article and Find Full Text PDF